Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Qualipharma AB
AB
Active
Org 5594341066
Vitmåravägen 87
Retail sale of pharmaceutical products · NACE 4773
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 1,4M
+751% vs 2024
EBITDA margin
29.7%
+176% vs 2024
Equity ratio
40.5%
Financial strength
Net profit 2025
SEK 320K
+268% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 1,4M
+751%
EBITDA
SEK 403K
+176%
Net profit
SEK 320K
+268%
Total assets
SEK 550K
+161%
Equity
SEK 223K
+99%
Employees
0
—
Company information
Legal name
Qualipharma AB
Org number
5594341066
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
15 maj 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska arbeta med att stötta apotek och läkemedelsföretag via projektledning och kunskap inom regulatory affairs i form av konsultuppdrag.
Contact
Address
Vitmåravägen 87
Email
n_al@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Upplands Väsby
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
160
1 358
Staff expenses
−7
—
EBITDA
146
403
Depreciation & amort.
—
−0
EBIT
146
403
Net financials
0
1
Profit before tax
110
403
Tax
−23
−83
Net profit
87
320
Balance sheet
SEK thousands
Item
2024
2025
Total assets
211
550
Equity
112
223
Long-term debt
—
0
Short-term debt
62
291
Total debt
62
291
Financial ratios
5-year trend
EBITDA margin
29.7%
This company
15.8%
Market median
+88% vs market
2024
2025
Equity ratio
40.5%
This company
38.2%
Market median
+6% vs market
2024
2025
Return on equity
143.5%
This company
18.4%
Market median
+680% vs market
2024
2025
Net profit margin
23.6%
This company
8.1%
Market median
+191% vs market
2024
2025
Asset turnover
2.47×
This company
1.12×
Market median
+121% vs market
2024
2025
Debt / equity
1.47×
This company
0.62×
Market median
-137% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-15 – 2024-04-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
NM
Nawras Mehenawi
Chief Executive Officer
Chief Executive Officer
2023
BA
Bashir Adem
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2023
Former (1)
HH
Haya Hadi
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2023 – 2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Qualipharma AB also hold positions in
0
other companies.
Person
Role here
Other companies
Nawras Mehenawi
Chief Executive Officer
0 companies
Haya Hadi
Deputy Chief Executive Officer
0 companies
Bashir Adem
Deputy Chief Executive Officer
0 companies